Your browser doesn't support javascript.
loading
Topical rapamycin (sirolimus) for the treatment of uncomplicated tufted angiomas in two children and review of the literature.
Burleigh, Angela; Kanigsberg, Nordau; Lam, Joseph M.
Afiliação
  • Burleigh A; Department of Dermatology, University of British Columbia, Vancouver, BC, Canada.
  • Kanigsberg N; Division of Dermatology, University of Ottawa, Ottawa, ON, Canada.
  • Lam JM; Department of Dermatology, University of British Columbia, Vancouver, BC, Canada.
Pediatr Dermatol ; 35(5): e286-e290, 2018 Sep.
Article em En | MEDLINE | ID: mdl-30015406
ABSTRACT
The mTOR inhibitor rapamycin is used systemically for the treatment of vascular lesions. We report the first use of topical rapamycin for the successful treatment of two cases of tufted angioma. The evidence for the use of topical rapamycin in other dermatologic conditions is summarized to aid in clinical decision making on preparations and anticipated side effects.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sirolimo / Hemangioma / Imunossupressores Tipo de estudo: Prognostic_studies Limite: Child / Female / Humans / Infant Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sirolimo / Hemangioma / Imunossupressores Tipo de estudo: Prognostic_studies Limite: Child / Female / Humans / Infant Idioma: En Ano de publicação: 2018 Tipo de documento: Article